Showing 181 - 200 results of 4,341 for search '"Journal for ImmunoTherapy of Cancer"', query time: 0.16s Refine Results
  1. 181
    959 Multiomic characterization of the tumor microenvironment in FFPE tissue by simultaneous protein and gene expression profiling

    959 Multiomic characterization of the tumor microenvironment in FFPE tissue by simultaneous protein and gene expression profiling by Hardeep Singh, Stephen Williams, Benton Veire, Alexander Hermes, Jun Chiang, Ace Santiago, Anuj Patel, David Sukovich, Lauren Gutgesell, Augusto Tentori

    Published 2023-11-01
    “…Journal for ImmunoTherapy of Cancer…”
    Article
  2. 182
    Genetic engineering of human NK cells to express CXCR2 improves migration to renal cell carcinoma

    Genetic engineering of human NK cells to express CXCR2 improves migration to renal cell carcinoma by Veronika Kremer, Marteen A. Ligtenberg, Rosa Zendehdel, Christina Seitz, Annet Duivenvoorden, Erik Wennerberg, Eugenia Colón, Ann-Helén Scherman-Plogell, Andreas Lundqvist

    Published 2017-09-01
    “…Journal for ImmunoTherapy of Cancer…”
    Get full text
    Article
  3. 183
    Efficacy of anti-PD-1 and ipilimumab alone or in combination in acral melanoma

    Efficacy of anti-PD-1 and ipilimumab alone or in combination in acral melanoma by Bart Neyns, Lisa Zimmer, Caroline Robert, Celeste Lebbe, Olivier Michielin, Omid Hamid, Anne Zaremba, Oliver Klein, Ruth Plummer, Joanna Mangana, Paolo A Ascierto, Katharina C Kähler, Georgina V Long, Ryan Sullivan, Grant A McArthur, Michael Weichenthal, Egle Ramelyte, Meghan J Mooradian, Douglas B Johnson, Alexander Shoushtari, Christian U Blank, Judith M Versluis, Prachi Bhave, Claudia Trojanello, Lu Si, Inderjit Mehmi, Tasnia Ahmed, Alexander M Menzies, Adnan Khattak, Severine Roy, Matteo S Carlino, Paul C Lorigan, Clara Allayous, Rachel Roberts-Thomson, Florentia Dimitriou, Kathleen Batty, Thierry Lesimple, Serigne N Lo, Alexandre Wicky, Richard Heywood, Lena Tran, Anna Stansfeld, Julia K Schwarze, Andrea Maurichi, Hui-Ling Yeoh, Mario Santinami, Andrew M Haydon

    Published 2022-07-01
    “…Journal for ImmunoTherapy of Cancer…”
    Get full text
    Article
  4. 184
    189 Systematic evaluation of transcriptomic molecular features in advanced renal clear cell carcinoma treated with immunotherapy

    189 Systematic evaluation of transcriptomic molecular features in advanced renal clear cell carcinoma treated with immunotherapy by Jian-Guo Zhou, Benjamin Frey, Hu Ma, Chi Zhang, Udo Gaipl

    Published 2023-11-01
    “…Journal for ImmunoTherapy of Cancer…”
    Article
  5. 185
    Distinct predictive biomarker candidates for response to anti-CTLA-4 and anti-PD-1 immunotherapy in melanoma patients

    Distinct predictive biomarker candidates for response to anti-CTLA-4 and anti-PD-1 immunotherapy in melanoma patients by Priyanka B. Subrahmanyam, Zhiwan Dong, Daniel Gusenleitner, Anita Giobbie-Hurder, Mariano Severgnini, Jun Zhou, Michael Manos, Lauren M. Eastman, Holden T. Maecker, F. Stephen Hodi

    Published 2018-03-01
    “…Journal for ImmunoTherapy of Cancer…”
    Get full text
    Article
  6. 186
    343 Defining and therapeutically targeting a fusion-derived public neoantigen in desmoplastic small round cell tumor using T-cell receptor gene therapy

    343 Defining and therapeutically targeting a fusion-derived public neoantigen in desmoplastic small round cell tumor using T-cell receptor gene therapy by Christopher A Klebanoff, Lauren Banks, Smita S Chandran, Hannah Arkin, Emily Slotkin, Neerav Shukla, Luc Morris, Andrew Kung, Martin Klatt

    Published 2023-11-01
    “…Journal for ImmunoTherapy of Cancer…”
    Article
  7. 187
    Intratumoral injection of TLR9 agonist promotes an immunopermissive microenvironment transition and causes cooperative antitumor activity in combination with anti-PD1 in pancreatic cancer

    Intratumoral injection of TLR9 agonist promotes an immunopermissive microenvironment transition and causes cooperative antitumor activity in combination with anti-PD1 in pancreatic... by Paola Cappello, Maurizio Martini, Aldo Scarpa, Stefano Ugel, Francesco De Sanctis, Giampaolo Tortora, Emilio Bria, Vincenzo Corbo, Carmine Carbone, Geny Piro, Antonio Agostini, Pietro Delfino, Vincenzo Nasca, Francesco Spallotta, Claudio Sette

    Published 2021-09-01
    “…Journal for ImmunoTherapy of Cancer…”
    Get full text
    Article
  8. 188
    Self-assembly nanovaccine containing TLR7/8 agonist and STAT3 inhibitor enhances tumor immunotherapy by augmenting tumor-specific immune response

    Self-assembly nanovaccine containing TLR7/8 agonist and STAT3 inhibitor enhances tumor immunotherapy by augmenting tumor-specific immune response by Yong He, Shusen Zheng, Shuai Wang, Jianxiang Chen, Lele Zhang, Jiacheng Huang, Xiaona Chen, Caixu Pan, Rong Su, Danjing Guo, Shengyong Yin, Yiting Qiao

    Published 2021-08-01
    “…Journal for ImmunoTherapy of Cancer…”
    Get full text
    Article
  9. 189
    Lower baseline autoantibody levels are associated with immune-related adverse events from immune checkpoint inhibition

    Lower baseline autoantibody levels are associated with immune-related adverse events from immune checkpoint inhibition by Anne R Bass, Michael Postow, Karmela K Chan, Deanna Jannat-Khah, Nilasha Ghosh, Quan-Zhen Li, Chengsong Zhu, Greg Vitone

    Published 2022-01-01
    “…Journal for ImmunoTherapy of Cancer…”
    Get full text
    Article
  10. 190
    535 Electroporation of B cells is correlated with cell size change during B cell expansion

    535 Electroporation of B cells is correlated with cell size change during B cell expansion by Jian Chen, George Sun

    Published 2020-11-01
    “…Journal for ImmunoTherapy of Cancer…”
    Article
  11. 191
    28 Toward an automated microfluidic platform for monitoring immune response to immunotherapy

    28 Toward an automated microfluidic platform for monitoring immune response to immunotherapy by Haidong Dong, YoHan Kim, Fabrice Lucien-Matteoni, Yuqian Zhang, Yuguang Liu

    Published 2023-11-01
    “…Journal for ImmunoTherapy of Cancer…”
    Article
  12. 192
    Guidelines for immunological analyses following focused ultrasound treatment

    Guidelines for immunological analyses following focused ultrasound treatment by Natasha D Sheybani, Frederic Padilla, Jessica Foley, Kelsie Timbie, Timothy N J Bullock

    Published 2023-11-01
    “…Journal for ImmunoTherapy of Cancer…”
    Get full text
    Article
  13. 193
    Novel peptide-based oncolytic vaccine for enhancement of adaptive antitumor immune response via co-engagement of innate Fcγ and Fcα receptors

    Novel peptide-based oncolytic vaccine for enhancement of adaptive antitumor immune response via co-engagement of innate Fcγ and Fcα receptors by Sari Pesonen, Sara Feola, Manlio Fusciello, Vincenzo Cerullo, Firas Hamdan, Jacopo Chiaro, Michaela Feodoroff, Gabriella Antignani, Salvatore Russo, Jeanette Leusen, Mikaela Grönholm, Federica D'Alessio, Riikka Mölsä, Virpi Stigzelius, Paolo Bottega

    Published 2024-03-01
    “…Journal for ImmunoTherapy of Cancer…”
    Get full text
    Article
  14. 194
    63 Infiltration by myeloid cells is an independent prognostic biomarker in vulvar squamous cell carcinoma, associated to stem cell-like features of the tumor

    63 Infiltration by myeloid cells is an independent prognostic biomarker in vulvar squamous cell carcinoma, associated to stem cell-like features of the tumor by Ziena Abdulrahman, Sjoerd van der Burg, Mariette van Poelgeest, Kim Kortekaas

    Published 2023-11-01
    “…Journal for ImmunoTherapy of Cancer…”
    Article
  15. 195
    911 Improved lifelines needed for all lines: real-world treatment patterns and attrition rates in US patients with non-driver mutation metastatic non-small cell lung cancer

    911 Improved lifelines needed for all lines: real-world treatment patterns and attrition rates in US patients with non-driver mutation metastatic non-small cell lung cancer by Chen Hu, Charlene Wong, Iftekhar Kalsekar, Qing Huang, Aisha Hasan, Josephine Feliciano, Adam Schoenfeld, Ravi Rajaram, Urmila Chandran, U Hariharan, Tianyi Wang

    Published 2023-11-01
    “…Journal for ImmunoTherapy of Cancer…”
    Article
  16. 196
    Phase I study of a multitargeted recombinant Ad5 PSA/MUC-1/brachyury-based immunotherapy vaccine in patients with metastatic castration-resistant prostate cancer (mCRPC)

    Phase I study of a multitargeted recombinant Ad5 PSA/MUC-1/brachyury-based immunotherapy vaccine in patients with metastatic castration-resistant prostate cancer (mCRPC) by Renee N Donahue, Jeffrey Schlom, James L Gulley, Ravi A Madan, Claudia Palena, Caroline Jochems, Shahrooz Rabizadeh, Patrick Soon-Shiong, Sheri McMahon, Julius Strauss, Marijo Bilusic, Fatima Karzai, Houssein Abdul Sater, Jennifer L Marté, Yo-Ting Tsai, Jason Redman, Charalampos Floudas

    Published 2021-03-01
    “…Journal for ImmunoTherapy of Cancer…”
    Get full text
    Article
  17. 197
    Corrections to: Checkpoint inhibitor therapy for cancer in solid organ transplantation recipients: an institutional experience and a systematic review of the literature

    Corrections to: Checkpoint inhibitor therapy for cancer in solid organ transplantation recipients: an institutional experience and a systematic review of the literature by Noha Abdel-Wahab, Houssein Safa, Ala Abudayyeh, Daniel H. Johnson, Van Anh Trinh, Chrystia M. Zobniw, Heather Lin, Michael K. Wong, Maen Abdelrahim, A. Osama Gaber, Maria E. Suarez-Almazor, Adi Diab

    Published 2019-06-01
    “…Journal for ImmunoTherapy of Cancer…”
    Get full text
    Article
  18. 198
    505 Relationship of infusion duration and dose to safety, efficacy and pharmacodynamics: second part of a phase 1–2 study using VSV-IFNβ-NIS (VV1) oncolytic virus in patients with refractory solid tumors

    505 Relationship of infusion duration and dose to safety, efficacy and pharmacodynamics: second part of a phase 1–2 study using VSV-IFNβ-NIS (VV1) oncolytic virus in patients with... by Manish Patel, Melissa Johnson, James Strauss, Timothy Cripe, Erol Wiegert, Monica Reckner, Alice Bexon, Kah-Whye Peng, Stephen Russell, Luke Russell, Jaime Merchan

    Published 2021-11-01
    “…Journal for ImmunoTherapy of Cancer…”
    Article
  19. 199
    795 APVO603: a dual 4-1BB and OX40 bispecific approach utilizing ADAPTIRTM technology designed to deliver a conditional T cell/NK response against solid tumors

    795 APVO603: a dual 4-1BB and OX40 bispecific approach utilizing ADAPTIRTM technology designed to deliver a conditional T cell/NK response against solid tumors by Michelle Nelson, Jane Gross, Catherine McMahan, Ashly Lucas, Rebecca Gottschalk, Hilario Ramos

    Published 2021-11-01
    “…Journal for ImmunoTherapy of Cancer…”
    Article
  20. 200
    405 Next-generation pan-cancer immunotherapy with patient-derived APC

    405 Next-generation pan-cancer immunotherapy with patient-derived APC by Yuan Liu, Lei Shi, Zhen Bian, Harry Stylli, Jane Zen

    Published 2023-11-01
    “…Journal for ImmunoTherapy of Cancer…”
    Article

Search Tools: